{"title":"再生障碍性贫血患者体内罕见的自身抗体模仿了抗 C 和抗 e 特异性。","authors":"Ping Ye, Guojin Ou","doi":"10.7754/Clin.Lab.2024.240817","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Alloantibodies for the Rh blood group are the most immunogenic antibodies found in the Chinese population, typically causing acute or delayed hemolytic transfusion reactions and fetal and neonatal hemolytic diseases. Autoantibodies are generally considered nonspecific, and approximately 50% of warm antibodies are secondary to a variety of diseases, especially hematologic tumors. In this case report, a rare autoantibody that mimics anti-C and anti-e specificity was identified.</p><p><strong>Methods: </strong>A 17-year-old adolescent with aplastic anemia was awaiting transfusion due to anemia. Routine laboratory testing before transfusion revealed that antibody screening was positive. Antibody identification and blood group antigen typing were performed to identify antibody specificity.</p><p><strong>Results: </strong>Antibodies in the patient's plasma and red blood cell release solution were identified as anti-C and anti-e specific. The patient's proximal red blood cells were separated by capillary centrifugation to identify the Rh blood group as DCeEe. Antibodies in the patient's plasma were suspected of being autoantibodies, a rare type of antibody. Screened C and e antigen-negative blood for transfusion was effective, and the patient's anemia was re-lieved. The patient was discharged after transfusion.</p><p><strong>Conclusions: </strong>Finding suitable blood for transfusion in patients with hemolytic anemia caused by warm autoantibodies is a challenge. Managed mimic antibodies are the same as alloantibodies, and matching-related antigen-negative blood is the first choice for transfusion in patients with mimic warm autoantibodies. However, C and e antigen-negative blood is rare among the Chinese population.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rare Autoantibody Mimics Anti-C and Anti-e Specificity in Patient with Aplastic Anemia.\",\"authors\":\"Ping Ye, Guojin Ou\",\"doi\":\"10.7754/Clin.Lab.2024.240817\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Alloantibodies for the Rh blood group are the most immunogenic antibodies found in the Chinese population, typically causing acute or delayed hemolytic transfusion reactions and fetal and neonatal hemolytic diseases. Autoantibodies are generally considered nonspecific, and approximately 50% of warm antibodies are secondary to a variety of diseases, especially hematologic tumors. In this case report, a rare autoantibody that mimics anti-C and anti-e specificity was identified.</p><p><strong>Methods: </strong>A 17-year-old adolescent with aplastic anemia was awaiting transfusion due to anemia. Routine laboratory testing before transfusion revealed that antibody screening was positive. Antibody identification and blood group antigen typing were performed to identify antibody specificity.</p><p><strong>Results: </strong>Antibodies in the patient's plasma and red blood cell release solution were identified as anti-C and anti-e specific. The patient's proximal red blood cells were separated by capillary centrifugation to identify the Rh blood group as DCeEe. Antibodies in the patient's plasma were suspected of being autoantibodies, a rare type of antibody. Screened C and e antigen-negative blood for transfusion was effective, and the patient's anemia was re-lieved. The patient was discharged after transfusion.</p><p><strong>Conclusions: </strong>Finding suitable blood for transfusion in patients with hemolytic anemia caused by warm autoantibodies is a challenge. Managed mimic antibodies are the same as alloantibodies, and matching-related antigen-negative blood is the first choice for transfusion in patients with mimic warm autoantibodies. However, C and e antigen-negative blood is rare among the Chinese population.</p>\",\"PeriodicalId\":10384,\"journal\":{\"name\":\"Clinical laboratory\",\"volume\":\"71 1\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical laboratory\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7754/Clin.Lab.2024.240817\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.240817","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:Rh血型自身抗体是中国人群中发现的免疫原性最强的抗体,通常会引起急性或迟发性溶血性输血反应以及胎儿和新生儿溶血性疾病。自身抗体一般被认为是非特异性的,约 50%的温抗体继发于多种疾病,尤其是血液系统肿瘤。在本病例报告中,发现了一种罕见的自身抗体,它模仿了抗C和抗E特异性:一名患有再生障碍性贫血的 17 岁青少年因贫血等待输血。输血前的常规实验室检测显示抗体筛查呈阳性。为确定抗体特异性,进行了抗体鉴定和血型抗原分型:结果:患者血浆和红细胞释放液中的抗体被鉴定为抗 C 和抗 E 特异性抗体。通过毛细管离心分离患者近端红细胞,确定其 Rh 血型为 DCeEe。患者血浆中的抗体被怀疑是自身抗体,这是一种罕见的抗体类型。筛查出的 C 抗原和 e 抗原阴性血液输血有效,患者的贫血症状得到缓解。输血后患者康复出院:为温性自身抗体引起的溶血性贫血患者寻找合适的输血是一项挑战。管理模拟抗体与同种抗体相同,匹配相关抗原阴性血液是模拟温性自身抗体患者输血的首选。然而,C 抗原和 e 抗原阴性血在中国人中很少见。
Rare Autoantibody Mimics Anti-C and Anti-e Specificity in Patient with Aplastic Anemia.
Background: Alloantibodies for the Rh blood group are the most immunogenic antibodies found in the Chinese population, typically causing acute or delayed hemolytic transfusion reactions and fetal and neonatal hemolytic diseases. Autoantibodies are generally considered nonspecific, and approximately 50% of warm antibodies are secondary to a variety of diseases, especially hematologic tumors. In this case report, a rare autoantibody that mimics anti-C and anti-e specificity was identified.
Methods: A 17-year-old adolescent with aplastic anemia was awaiting transfusion due to anemia. Routine laboratory testing before transfusion revealed that antibody screening was positive. Antibody identification and blood group antigen typing were performed to identify antibody specificity.
Results: Antibodies in the patient's plasma and red blood cell release solution were identified as anti-C and anti-e specific. The patient's proximal red blood cells were separated by capillary centrifugation to identify the Rh blood group as DCeEe. Antibodies in the patient's plasma were suspected of being autoantibodies, a rare type of antibody. Screened C and e antigen-negative blood for transfusion was effective, and the patient's anemia was re-lieved. The patient was discharged after transfusion.
Conclusions: Finding suitable blood for transfusion in patients with hemolytic anemia caused by warm autoantibodies is a challenge. Managed mimic antibodies are the same as alloantibodies, and matching-related antigen-negative blood is the first choice for transfusion in patients with mimic warm autoantibodies. However, C and e antigen-negative blood is rare among the Chinese population.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.